Hey all,
I’m currently a 2nd-year associate on a life sciences royalty team in private equity. I have a science undergraduate degree, followed by an MBA and CFA. I've spent a few years in banking, both full-time and through internships, and I'm quite confident with my modeling skills.
Right now, I do enjoy my role, especially attending healthcare conferences and conducting scientific and financial due diligence. My focus is mainly on commercialized assets and a few pre-approval projects, with analysis often taking several weeks. However, I'm looking for something new and more fast-paced with higher earning potential, so I'm considering transitioning to a life sciences long/short hedge fund. I understand the risks involved but am excited about the challenge. I've had conversations with a few recruiters and members of these firms, and they always probe my interest in transitioning to their L/S firm. I want to make sure I'm prepared since I know that just because I've done well in the royalty side, it doesn't mean the L/S side will be the same.
I know hedge funds require more rapid idea generation and analysis for every meeting, which is quite different from the more extended analysis cycle I'm used to.
Note: I adjusted the questions to be more specific as the ones I previously had were a bit too generic and didn't convey what I wanted
Questions:
-
How does the clinical analysis done at an L/S fund vary from that of a PE fund? With quicker timelines, do you go as deep into the fundamental models? Do you still talk to as many KOLs and physicians in the space?
-
With event-driven strategies, is the focus more on the likelihood of approval of a drug and PDUFA timelines as opposed to whether it will be successful commercially and future products in the pipeline that could be competitors 2-3 years down the road?
-
What should I be reading, and how, if at all, should I be adjusting my learning and focus to prepare? What would be the biggest shift from moving from royalty investing in commercialized and some pre-approval high-conviction assets to an L/S fund focusing on event-driven strategies?
Any advice or insights would be greatly appreciated!
Thanks!
Officia dignissimos et dolor occaecati aut ex. Tenetur amet temporibus neque ducimus dolore sit. Eaque eos neque rem velit. Quod voluptatem repellat exercitationem omnis autem aspernatur omnis alias.
Voluptas perspiciatis reiciendis voluptate sunt sed. Beatae repudiandae officiis voluptatem molestiae nihil ut. Ut eos eum aut sint qui dignissimos deserunt totam.
Vel et molestias sed sint at ut rerum. Numquam repellat maiores quaerat ut.
Assumenda iure dolore voluptates sunt. Minima aut mollitia laborum omnis accusamus cupiditate. Corrupti impedit doloribus sed ipsam.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...